We serve Boc-4-nitro-L-phenylalanine CAS:33305-77-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Boc-4-nitro-L-phenylalanine
CAS.NO: 33305-77-0
Molecular Formula: C14H18N2O6
Molecular Weight: 310.30300
Synonyms:
N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-4-nitro-L-phenylalanine
Boc-4-Nitro-L-Phenylalanine
BOC-PHE(P-NO2)-OH
Boc-L-4-NO2-Phe-OH
BOC-L-4-NITROPHE
Boc-D-phe(4-NO2)-OH
BOC-(P-NO2)PHE-OH
N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-4-nitrophenylalanine
Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-4-nitro-
BOC-P-NITRO-PHE-OH
N-(t-butyloxycarbonyl)-4-nitro-D,L-phenylalanine
L-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-4-nitro-
Boc-Phe(4-NO2)-OH
N-tert-butoxycarbonyl-p-nitro-L-phenylalanine
BOC-PNO2-L-PHE-OH
BOC-4-NITRO-PHE-OH
n-(tert-butoxycarbonyl)-4-nitrophenylalanine
BOC-L-PHE(4-NO2)
(S)-2-t-butyloxycarbonylamino-3-(4-nitrophenyl)propionic acid
Physical and Chemical Properties:
Density: 1.29 g / cm3
Boiling point: 509.3ºC at 760 mmHg
Melting point: 107ºC
Flash point: 261.8ºC
Refractive index: 1.553
Specification:
Appearance: White powder
Purity:≥99%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:-20ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.
Contact us for information like Boc-4-nitro-L-phenylalanine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-2-t-butyloxycarbonylamino-3-(4-nitrophenyl)propionic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,BOC-L-4-NITROPHE Use and application,Boc-4-Nitro-L-Phenylalanine technical grade,usp/ep/jp grade.
Related News: Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.toluene-4-sulfonic acid (R)-(tetrahydro-furan-3-yl) ester manufacturer Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.1-phenylcyclopentane-1-carbonyl chloride supplier The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.N-phenacylacetamide vendor At the same time, due to the relatively late development of the bulk drug business in China, most of the established bulk drug companies are currently in the field of commonly used generic drug bulk drugs. Stand up.Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China.
